Search

Close
Research
Home > Research > Faculty
Research

NI Yueqiong  

  • Doctoral Supervisor, Researcher
  • Department: Endocrinology and Metabolism
  • Research Area: Internal Medicine (Endocrinology and Metabolism)
  • Research Interests: Systems Biomedicine of Metabolic diseases; Human Microbiota
  • Contact: bernard_ni@sjtu.edu.cn
Biography Publications Research Projects
  • Postdoc at Leibniz Hans Knoll Institute Germany, 2018.02-2024.12
  • PhD from The University of Hong Kong, 2013.12-2018.01
  • MRes from The University of York/Shanghai Jiao Tong University, 2012.10-2013.10
  • BSc from Xi'an Jiao Tong-Liverpool University, 2008.09-2012.07
  1. Zhang, L., Marfil-Sánchez, A., Kuo, T. H., Seelbinder, B., van Dam, L., Depetris-Chauvin, A., Jahn, L. J., Sommer, M. O. A., Zimmermann, M., Ni, Y.*, & Panagiotou, G*. (2026). Gut microbiome-mediated transformation of dietary phytonutrients is associated with health outcomes. Nature microbiology, 11(1), 94–110.
  2. Long X, Wang H, Lu Y, Gao X, Xiao Y, Zhang M, Guo J, Yang J, Zhang R, Li Q, Zhou G, Yang R, Chen F, Wu Q, Sun L, Chu C, Zhu X, Wu Z, Ren Q, You C, Liu Z, Li Q, Liu D, Cheng D, Kang P, Chen A, Wu Q, Fang Q, Wei L, Zhang L, Li J, Panagiotou G, Jia W*, Zeng R*, Ni Y*, Chen L*, Li H*. Interindividual variability in gut microbiome mediates the efficacy of resistant starch on MASLD. Cell Metab. 2025 Dec 2;37(12):2342-2361.e9. doi: 10.1016/j.cmet.2025.10.017.
  3. Ni Y, Qian L, Leal Siliceo S, Long X, Nychas E, Liu Y, Ismaiah MJ, Leung H, Zhang L, Gao Q, Wu Q, Zhang Y, Jia Xi, Liu S, Yuan R, Zhou L, Wang X, Li Q, Zhao Y, El-Nezami H, Xu A, Xu G, Li H, Panagiotou G, Jia W (2023) Resistant starch decreases intrahepatic triglycerides in NAFLD patients via gut microbiome alterations. Cell Metabolism 35, 1530-1547.
  4. Leung H#, Long X#, Ni Y*, Qian L, Nychas E, Siliceo SL, Pohl D, Hanhineva K, Liu Y, Xu A, Nielsen HB, Belda E, Clément K, Loomba R, Li H*, Jia W*, Panagiotou G*. Risk assessment with gut microbiome and metabolite markers in NAFLD development. Sci Transl Med. 2022 Jun 8;14(648):eabk0855.
  5. Liu Y#, Wang Y#, Ni Y#, Cheung CKY, Lam KSL, Wang Y, Xia Z, Ye D, Guo J, Tse MA, Panagiotou G, Xu A (2020) Gut microbiome fermentation determines the efficacy of exercise for diabetes prevention. Cell Metabolism 31(1), 77-91.
  6. Wang J#, Qin Y#, Wu Q#, Zeng D#, Gao X#, Wang Q#, Li Z#, Ni Y#, Li H#, Zhang P#, Guo J#, Ma W, Maitusun M, Jin X, Chen M, Zhu L, Lu Q, Chen Q, Wu Y, Lin C, Han R, Cheng D, Ni J, Wang X, Yao F, Zhuang J, Xia J, Liu D, Lu Y, Kang P, Yu S, Chen A, Zhang Y, Li Q, Ge W, Long X, Jiang Z, Guan Z, Jin Z, Jin P, Li T, Shu J, Yang J, Wang J, Jiang N, Qian J, Jung Y, Zhang H, Yang Q, Ma L, Wu X, Huang X, Si D, Ren J, Qiao H, Guo Y, Huang Z, Wang W, Deng W, Bi L, Zhao D, Li Y, Lau RWH, Tham YC, Ma X, Ma J, Shen D, Zhang S, Guan H, Zou W, Guo M, Guan X, Yang X, Xu A, Wu J, Panagiotou G, Tse MA, Kim J, Wu E, Thalmann D, Magnenat Thalmann N, Fregni F, Wong TY, Jia W, Zeng R#, Lim CT#, Sheng B#, Li H# (2025) An adaptive AI-based virtual reality sports system for adolescents with excess body weight: a randomized controlled trial. Nature Medicine 31(7), 2255-2268. 
  7. Nychas E#, Marfil-Sánchez A#, Chen X, Mirhakkak M, Li H, Jia Q, Xu A, Nielsen HB, Niewdorp M, Loomba R, Ni Y*, Panagiotou G* (2025) Discovery of robust and highly specific microbiome signatures of non-alcoholic fatty liver disease. Microbiome 13(1), 10.
  8. Zhang J#, Ni Y#, Qian L, Fang Q, Zheng T, Zhang, M, Gao Q, Zhang Y, Ni, J, Bao Y, Kovatcheva-Datchary P, Xu A, Li H, Panagiotou G, Jia W (2021) Decreased abundance of Akkermansia muciniphila leads to the impairment of insulin secretion and glucose homeostasis in lean type 2 diabetes. Advanced Science. 2021 Jun 4;e2100536.
  9. Ni Y, Lohinai Z, Heshiki Y, Dome B, Moldvay J, Dulka E, Gallfy G, Berta J, Weiss G, Sommer MOA, Panagiotou G (2021) Distinct composition and metabolic functions of human gut microbiota are associated with cachexia in lung cancer patients. ISME J. 2021 May 17. doi: 10.1038/s41396-021-00998-8. 
  10. Heshiki Y#, Vazquez-Uribe R#, Li J#, Ni Y#, Quainoo S, Imamovic L, Li J, Sørensen M, Chow BKC, Weiss GJ, Xu A, Sommer MOA, Panagiotou G (2020) Predictable modulation of cancer treatment outcomes by the gut microbiota. Microbiome 8(1), 28.
     
  • 01/01/2026-12/31/2028
    National Natural Science Foundation of China (Key Program), ¥300,000, 82501033
    Multiomics-driven study of the effect and mechanism of gut microbiota on the efficacy of resistant starch in alleviating MASLD
    Role: Principal Investigator

Copyright © 2024, All Rights Reserved.